India, Aug. 24 -- InterCure Ltd. (INCR) announced that it has finalized a settlement with the Israeli Tax Authorities and Compensation Fund for indirect damages sustained during the October 7, 2023 attacks and the subsequent war.
The agreement provides compensation totaling NIS 230 million (approximately US$77 million).
The settlement follows an earlier claim of more than NIS 300 million, of which InterCure has already received NIS 101 million in advance payments.
The funds will accelerate rehabilitation of Canndoc's flagship cultivation and production facility at Kibbutz Nir Oz, which was severely damaged and rendered inoperable during the attacks. The facility is a cornerstone of InterCure's genetics, cultivation and production infrast...